News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
752,204 Results
Type
Article (64679)
Company Profile (296)
Press Release (687229)
Multimedia
Podcasts (59)
Webinars (12)
Section
Business (212816)
Career Advice (2377)
Deals (36416)
Drug Delivery (101)
Drug Development (84534)
Employer Resources (178)
FDA (16599)
Job Trends (15564)
News (359583)
Policy (34032)
Tag
Academia (2923)
Academic (1)
Accelerated approval (5)
Adcomms (22)
Allergies (88)
Alliances (52862)
ALS (96)
Alzheimer's disease (1457)
Antibody-drug conjugate (ADC) (137)
Approvals (16590)
Artificial intelligence (277)
Autoimmune disease (24)
Automation (16)
Bankruptcy (366)
Best Places to Work (11965)
BIOSECURE Act (20)
Biosimilars (108)
Biotechnology (202)
Bladder cancer (78)
Brain cancer (29)
Breast cancer (292)
Cancer (2357)
Cardiovascular disease (186)
Career advice (1986)
Career pathing (32)
CAR-T (159)
Cell therapy (452)
Cervical cancer (21)
Clinical research (68232)
Collaboration (894)
Company closure (1)
Compensation (551)
Complete response letters (20)
COVID-19 (2775)
CRISPR (44)
C-suite (266)
Cystic fibrosis (106)
Data (2304)
Decentralized trials (2)
Denatured (21)
Depression (49)
Diabetes (281)
Diagnostics (6600)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (126)
Drug pricing (106)
Drug shortages (25)
Duchenne muscular dystrophy (98)
Earnings (88087)
Editorial (44)
Employer branding (22)
Employer resources (153)
Events (117090)
Executive appointments (763)
FDA (17940)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (800)
Gene editing (114)
Generative AI (23)
Gene therapy (326)
GLP-1 (752)
Government (4671)
Grass and pollen (5)
Guidances (108)
Healthcare (19618)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (124)
Indications (30)
Infectious disease (2926)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (54)
Intellectual property (98)
Interviews (406)
IPO (16788)
IRA (44)
Job creations (4022)
Job search strategy (1686)
Kidney cancer (10)
Labor market (40)
Layoffs (500)
Leadership (19)
Legal (8238)
Liver cancer (78)
Lung cancer (330)
Lymphoma (156)
Machine learning (8)
Management (61)
Manufacturing (332)
MASH (73)
Medical device (13684)
Medtech (13689)
Mergers & acquisitions (20187)
Metabolic disorders (721)
Multiple sclerosis (85)
NASH (16)
Neurodegenerative disease (98)
Neuropsychiatric disorders (27)
Neuroscience (2024)
NextGen: Class of 2025 (6828)
Non-profit (4854)
Now hiring (40)
Obesity (381)
Opinion (224)
Ovarian cancer (78)
Pain (95)
Pancreatic cancer (89)
Parkinson's disease (153)
Partnered (22)
Patents (244)
Patient recruitment (116)
Peanut (48)
People (60197)
Pharmaceutical (69)
Pharmacy benefit managers (19)
Phase I (21288)
Phase II (29932)
Phase III (22223)
Pipeline (1292)
Policy (154)
Postmarket research (2942)
Preclinical (9600)
Press Release (70)
Prostate cancer (110)
Psychedelics (33)
Radiopharmaceuticals (259)
Rare diseases (396)
Real estate (6495)
Recruiting (67)
Regulatory (23290)
Reports (46)
Research institute (2627)
Resumes & cover letters (391)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (74)
Series A (135)
Series B (88)
Service/supplier (18)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3833)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (48)
The Weekly (36)
Vaccines (750)
Venture capitalists (41)
Weight loss (250)
Women's health (36)
Worklife (17)
Date
Today (294)
Last 7 days (881)
Last 30 days (2978)
Last 365 days (33456)
2025 (11574)
2024 (36140)
2023 (41092)
2022 (52374)
2021 (56996)
2020 (55710)
2019 (48566)
2018 (36658)
2017 (33898)
2016 (33922)
2015 (40490)
2014 (34389)
2013 (30584)
2012 (32246)
2011 (32577)
2010 (31151)
Location
Africa (881)
Alabama (55)
Alaska (7)
Arizona (246)
Arkansas (13)
Asia (41756)
Australia (7276)
California (6350)
Canada (2071)
China (548)
Colorado (275)
Connecticut (280)
Delaware (156)
Europe (93711)
Florida (938)
Georgia (213)
Idaho (58)
Illinois (569)
India (27)
Indiana (317)
Iowa (11)
Japan (171)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (928)
Massachusetts (4763)
Michigan (222)
Minnesota (409)
Mississippi (2)
Missouri (82)
Montana (30)
Nebraska (25)
Nevada (66)
New Hampshire (65)
New Jersey (1785)
New Mexico (31)
New York (1807)
North Carolina (1043)
North Dakota (9)
Northern California (2775)
Ohio (213)
Oklahoma (14)
Oregon (35)
Pennsylvania (1417)
Puerto Rico (13)
Rhode Island (33)
South America (1248)
South Carolina (26)
South Dakota (1)
Southern California (2381)
Tennessee (105)
Texas (950)
United States (24039)
Utah (192)
Virginia (156)
Washington D.C. (68)
Washington State (569)
West Virginia (3)
Wisconsin (59)
752,204 Results for "toronto research chemicals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SMSbiotech Establishes a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Chemical Defense
April 22, 2025
·
1 min read
Business
University of Toronto scientists appointed as GSK chairs will advance drug delivery research and vaccine education tools for healthcare professionals
The University of Toronto’s Leslie Dan Faculty of Pharmacy has announced the appointments of two leading scientists as endowed GSK research chairs.
April 23, 2024
·
5 min read
Press Releases
Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.
May 7, 2025
·
3 min read
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
Press Releases
Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
April 22, 2025
·
5 min read
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
BioMidwest
Chemical Insights Research Institute Shares its Latest Research Findings on PFAS Associated with Consumer and Commercial Textiles
Chemical Insights Research Institute of UL Research Institutes has released its first report on a multi-phase research study of per- and polyfluoroalkyl substances, commonly referred to as “forever chemicals,” associated with consumer and commercial textiles.
March 27, 2024
·
3 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
2 min read
Press Releases
Heart Disease Deaths Worldwide Linked to Chemical Widely Used in Plastics
April 29, 2025
·
6 min read
Bio NC
Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto
Caidya, a leading global, multi-therapeutic clinical research organization, is pleased to announce the establishment of its new legal entity, Caidya Canada Limited, and the opening of its new office in Toronto, Ontario.
April 1, 2024
·
2 min read
1 of 75,221
Next
